Hadasit Bio Stock Working Capital
| HDST Stock | 53.00 0.00 0.00% |
Hadasit Bio fundamentals help investors to digest information that contributes to Hadasit Bio's financial success or failures. It also enables traders to predict the movement of Hadasit Stock. The fundamental analysis module provides a way to measure Hadasit Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hadasit Bio stock.
Hadasit |
Hadasit Bio Company Working Capital Analysis
Hadasit Bio's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Hadasit Bio Working Capital | 59 M |
Most of Hadasit Bio's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hadasit Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
According to the company's disclosures, Hadasit Bio has a Working Capital of 59 M. This is 86.14% lower than that of the Biotechnology sector and 89.05% lower than that of the Health Care industry. The working capital for all Israel stocks is 96.01% higher than that of the company.
Hadasit Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hadasit Bio's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hadasit Bio could also be used in its relative valuation, which is a method of valuing Hadasit Bio by comparing valuation metrics of similar companies.Hadasit Bio is currently under evaluation in working capital category among related companies.
Hadasit Fundamentals
| Return On Equity | -0.44 | |||
| Return On Asset | -0.0296 | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | (3.4 M) | |||
| Shares Outstanding | 11.09 M | |||
| Shares Owned By Insiders | 74.99 % | |||
| Price To Book | 0.52 X | |||
| Price To Sales | 0.90 X | |||
| Gross Profit | 35.09 M | |||
| EBITDA | 28.67 M | |||
| Net Income | 28.36 M | |||
| Cash And Equivalents | 18.14 M | |||
| Cash Per Share | 1.64 X | |||
| Debt To Equity | 0.40 % | |||
| Current Ratio | 17.76 X | |||
| Book Value Per Share | 3.59 X | |||
| Cash Flow From Operations | (2.1 M) | |||
| Earnings Per Share | 2.46 X | |||
| Beta | 0.58 | |||
| Market Capitalization | 16.9 M | |||
| Total Asset | 66.41 M | |||
| Retained Earnings | (125 M) | |||
| Working Capital | 59 M | |||
| Current Asset | 61 M | |||
| Current Liabilities | 2 M | |||
| Z Score | -1.4 | |||
| Annual Yield | 0.18 % | |||
| Net Asset | 66.41 M |
About Hadasit Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hadasit Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hadasit Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hadasit Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hadasit Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Hadasit Stock analysis
When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |